<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Invo Fertility, Inc. — News on 6ix</title>
<link>https://6ix.com/company/invo-fertility-inc</link>
<description>Latest news and press releases for Invo Fertility, Inc. on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Wed, 29 Apr 2026 20:05:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/invo-fertility-inc" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo6835865378dffbe2df0fde60.webp</url>
<title>Invo Fertility, Inc.</title>
<link>https://6ix.com/company/invo-fertility-inc</link>
</image>
<item>
<title>INVO Fertility Receives Nasdaq Notification Regarding Late Filing of Annual Report on Form 10-K</title>
<link>https://6ix.com/company/invo-fertility-inc/news/invo-fertility-receives-nasdaq-notification-regarding-late-filing-of-annual-report-on-form-10-k</link>
<guid isPermaLink="true">https://6ix.com/company/invo-fertility-inc/news/invo-fertility-receives-nasdaq-notification-regarding-late-filing-of-annual-report-on-form-10-k</guid>
<pubDate>Wed, 29 Apr 2026 20:05:00 GMT</pubDate>
<description>SARASOTA, Fla., April 29, 2026 (GLOBE NEWSWIRE) -- INVO Fertility, Inc. (Nasdaq: IVF) (“INVO” or the “Company”), a healthcare services fertility company focused on expanding access to advanced reproductive treatment through the establishment, acquisition and operation of fertility clinics and related businesses and technologies, today announced that on April 23, 2026, it received a written notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”)</description>
</item>
<item>
<title>INVO Fertility Announces a 1:5 Reverse Stock Split Effective Pre-Market Opening on March 27, 2026</title>
<link>https://6ix.com/company/invo-fertility-inc/news/invo-fertility-announces-a-15-reverse-stock-split-effective-pre-market-opening-on-march-27-2026</link>
<guid isPermaLink="true">https://6ix.com/company/invo-fertility-inc/news/invo-fertility-announces-a-15-reverse-stock-split-effective-pre-market-opening-on-march-27-2026</guid>
<pubDate>Wed, 25 Mar 2026 04:00:00 GMT</pubDate>
<description>SARASOTA, Fla., March 25, 2026 (GLOBE NEWSWIRE) -- INVO Fertility, Inc. (“INVO”) (NASDAQ: IVF), a healthcare company focused on the fertility market,</description>
</item>
<item>
<title>INVO Fertility Announces Availability of Advanced Incubation Technology at its Wisconsin Clinic</title>
<link>https://6ix.com/company/invo-fertility-inc/news/invo-fertility-announces-availability-of-advanced-incubation-technology-at-its-wisconsin-clinic-58</link>
<guid isPermaLink="true">https://6ix.com/company/invo-fertility-inc/news/invo-fertility-announces-availability-of-advanced-incubation-technology-at-its-wisconsin-clinic-58</guid>
<pubDate>Thu, 05 Mar 2026 05:00:00 GMT</pubDate>
<description>Time-Lapse Incubation Provides Additional Cutting-Edge Solution for Patient Care SARASOTA, Fla., March 05, 2026 (GLOBE NEWSWIRE) -- INVO Fertility, Inc.</description>
</item>
<item>
<title>INVO Fertility’s Wisconsin Clinic Joins Progyny Network</title>
<link>https://6ix.com/company/invo-fertility-inc/news/invo-fertilitys-wisconsin-clinic-joins-progyny-network</link>
<guid isPermaLink="true">https://6ix.com/company/invo-fertility-inc/news/invo-fertilitys-wisconsin-clinic-joins-progyny-network</guid>
<pubDate>Tue, 03 Mar 2026 05:00:00 GMT</pubDate>
<description>INVO’s Wisconsin Clinic is now in-network for Progyny members, expanding the clinic’s market reach MIDDLETON, Wis. and SARASOTA, Fla., March 03, 2026 (GLOBE</description>
</item>
<item>
<title>INVO Fertility Closes Acquisition of Indiana-Based Fertility Clinic “Family Beginnings”</title>
<link>https://6ix.com/company/invo-fertility-inc/news/invo-fertility-closes-acquisition-of-indiana-based-fertility-clinic-family-beginnings</link>
<guid isPermaLink="true">https://6ix.com/company/invo-fertility-inc/news/invo-fertility-closes-acquisition-of-indiana-based-fertility-clinic-family-beginnings</guid>
<pubDate>Thu, 19 Feb 2026 13:30:00 GMT</pubDate>
<description>Strategic Transaction Advances Company’s GrowthSARASOTA, Fla., Feb. 19, 2026 (GLOBE NEWSWIRE) -- INVO Fertility, Inc. (Nasdaq: IVF) (“INVO” or the “Company”), a healthcare fertility company focused on the establishment, acquisition, and operation of fertility clinics and related businesses and technologies, today announced that it has successfully closed the previously announced acquisition of Family Beginnings, P.C., a respected fertility clinic serving patients across Indiana and the broader M</description>
</item>
<item>
<title>INVO Fertility Announces Patent Issuance for Modified INVOcell® Device</title>
<link>https://6ix.com/company/invo-fertility-inc/news/invo-fertility-announces-patent-issuance-133000183</link>
<guid isPermaLink="true">https://6ix.com/company/invo-fertility-inc/news/invo-fertility-announces-patent-issuance-133000183</guid>
<pubDate>Wed, 11 Feb 2026 13:30:00 GMT</pubDate>
<description>New patent extends intellectual property protection on the Company’s INVOcell device through 2040SARASOTA, Fla., Feb. 11, 2026 (GLOBE NEWSWIRE) -- INVO Fertility, Inc. (Nasdaq: IVF) (“INVO” or the “Company”), a healthcare fertility company focused on the establishment, acquisition, and operation of fertility clinics and related businesses and technologies, today announced the final issuance of a U.S. patent covering a modified version of its proprietary INVOcell® device. The patent (U.S. Patent</description>
</item>
<item>
<title>INVO Fertility Issues Shareholder Letter Highlighting Strengthened Fundamental Position and Strategic Outlook for Growth</title>
<link>https://6ix.com/company/invo-fertility-inc/news/invo-fertility-issues-shareholder-letter-140000969</link>
<guid isPermaLink="true">https://6ix.com/company/invo-fertility-inc/news/invo-fertility-issues-shareholder-letter-140000969</guid>
<pubDate>Wed, 04 Feb 2026 14:00:00 GMT</pubDate>
<description>SARASOTA, Fla., Feb. 04, 2026 (GLOBE NEWSWIRE) -- INVO Fertility, Inc. (Nasdaq: IVF) (“INVO” or the “Company”), a healthcare fertility company focused on the establishment, acquisition, and operation of fertility clinics and related businesses and technologies, today issued a shareholder letter from its Chief Executive Officer, Steve Shum, outlining the Company’s strengthened fundamental position and its strategic outlook for continued growth. In the letter, management highlights meaningful prog</description>
</item>
<item>
<title>INVO Fertility Enters into $7.5 Million Warrant Inducement Priced At-the-Market Under Nasdaq Rules</title>
<link>https://6ix.com/company/invo-fertility-inc/news/invo-fertility-enters-7-5-133000870</link>
<guid isPermaLink="true">https://6ix.com/company/invo-fertility-inc/news/invo-fertility-enters-7-5-133000870</guid>
<pubDate>Thu, 29 Jan 2026 13:30:00 GMT</pubDate>
<description>SARASOTA, Fla., Jan. 29, 2026 (GLOBE NEWSWIRE) -- INVO Fertility Inc. (“INVO” or the “Company”) (NASDAQ: IVF), a healthcare company focused on the fertility market, today announced it has entered into a warrant inducement agreement with an investor (“Investor”) for the immediate exercise of certain outstanding warrants that the Company issued on December 3, 2025 (the “December 2025 Warrants”). Pursuant to a warrant inducement agreement, the Investor has agreed to a reduced exercise price of the</description>
</item>
<item>
<title>INVO Fertility to Participate in the Lytham Partners 2026 Investor Healthcare Summit on January 15, 2026</title>
<link>https://6ix.com/company/invo-fertility-inc/news/invo-fertility-participate-lytham-partners-211500800</link>
<guid isPermaLink="true">https://6ix.com/company/invo-fertility-inc/news/invo-fertility-participate-lytham-partners-211500800</guid>
<pubDate>Tue, 13 Jan 2026 21:15:00 GMT</pubDate>
<description>SARASOTA, Fla., Jan. 13, 2026 (GLOBE NEWSWIRE) -- INVO Fertility, Inc. (Nasdaq: IVF) (“INVO” or the “Company”), a healthcare fertility company focused on the establishment, acquisition, and operation of fertility clinics and related businesses and technologies, today announced that it will participate in a webcast fireside chat at the Lytham Partners 2026 Investor Healthcare Summit, taking place virtually on Thursday, January 15, 2026. The webcast will take place at 3:00 p.m. ET on Thursday, Jan</description>
</item>
<item>
<title>INVO Fertility Aligns Executive Leadership Structure to Support Growth Strategy</title>
<link>https://6ix.com/company/invo-fertility-inc/news/invo-fertility-aligns-executive-leadership-210500020</link>
<guid isPermaLink="true">https://6ix.com/company/invo-fertility-inc/news/invo-fertility-aligns-executive-leadership-210500020</guid>
<pubDate>Tue, 30 Dec 2025 21:05:00 GMT</pubDate>
<description>Terah Krigsvold to replace Andrea Goren as CFO, who is named chief business officer and CEO of INVO Centers LLC to focus on growth effortsSARASOTA, Fla., Dec. 30, 2025 (GLOBE NEWSWIRE) -- INVO Fertility, Inc. (Nasdaq: IVF) (“INVO” or the “Company”), a healthcare fertility company focused on the establishment, acquisition, and operation of fertility clinics and related businesses and technologies, today announced changes to its executive leadership team to align its human resources with the Compa</description>
</item>
<item>
<title>INVO Fertility Signs Definitive Purchase Agreement to Acquire Indiana-Based Fertility Clinic “Family Beginnings”</title>
<link>https://6ix.com/company/invo-fertility-inc/news/invo-fertility-signs-definitive-purchase-140000644</link>
<guid isPermaLink="true">https://6ix.com/company/invo-fertility-inc/news/invo-fertility-signs-definitive-purchase-140000644</guid>
<pubDate>Wed, 17 Dec 2025 14:00:00 GMT</pubDate>
<description>Signing of definitive purchase agreement represents critical next step in completing previously announced acquisitionSARASOTA, Fla. and INDIANAPOLIS, Dec. 17, 2025 (GLOBE NEWSWIRE) -- INVO Fertility, Inc. (Nasdaq: IVF) (“INVO” or the “Company”), a healthcare fertility company focused on the establishment, acquisition, and operation of fertility clinics and related businesses and technologies, today announced that it has signed a definitive purchase agreement to acquire Family Beginnings, P.C., a</description>
</item>
<item>
<title>INVO Fertility Announces Pricing of $4.0 Million Private Placement Priced At-The-Market Under Nasdaq Rules</title>
<link>https://6ix.com/company/invo-fertility-inc/news/invo-fertility-announces-pricing-4-142500442</link>
<guid isPermaLink="true">https://6ix.com/company/invo-fertility-inc/news/invo-fertility-announces-pricing-4-142500442</guid>
<pubDate>Tue, 02 Dec 2025 14:25:00 GMT</pubDate>
<description>SARASOTA, Fla., Dec. 02, 2025 (GLOBE NEWSWIRE) -- INVO Fertility, Inc. (“INVO” or the “Company”) (NASDAQ: IVF), a healthcare company focused on the fertility market, today announced that it has entered into a securities purchase agreement with a single institutional investor to purchase 2,366,864 shares of common stock (or pre-funded warrants in-lieu thereof), together with warrants to purchase up to an aggregate 4,733,728 shares of common stock, in a private placement priced at-the-market under</description>
</item>
<item>
<title>INVO Fertility Announces Intent to Acquire Indiana-Based Fertility Clinic “Family Beginnings”</title>
<link>https://6ix.com/company/invo-fertility-inc/news/invo-fertility-announces-intent-acquire-180500316</link>
<guid isPermaLink="true">https://6ix.com/company/invo-fertility-inc/news/invo-fertility-announces-intent-acquire-180500316</guid>
<pubDate>Fri, 28 Nov 2025 18:05:00 GMT</pubDate>
<description>Acquisition advances INVO’s national expansion strategy, enhances its clinical capabilities, and broadens access to innovative fertility care across the MidwestSARASOTA, Fla. and INDIANAPOLIS, Nov. 28, 2025 (GLOBE NEWSWIRE) -- INVO Fertility, Inc. (Nasdaq: IVF) (“INVO” or the “Company”), a healthcare fertility company focused on the establishment, acquisition, and operation of fertility clinics and related businesses and technologies, today announced its intent to acquire Family Beginnings, P.C.</description>
</item>
<item>
<title>INVO Fertility Announces a 1:8 Reverse Stock Split Effective Pre-Market Opening on November 28, 2025</title>
<link>https://6ix.com/company/invo-fertility-inc/news/invo-fertility-announces-1-8-140000909</link>
<guid isPermaLink="true">https://6ix.com/company/invo-fertility-inc/news/invo-fertility-announces-1-8-140000909</guid>
<pubDate>Tue, 25 Nov 2025 14:00:00 GMT</pubDate>
<description>SARASOTA, Fla., Nov. 25, 2025 (GLOBE NEWSWIRE) -- INVO Fertility, Inc. (“INVO”) (NASDAQ: IVF), a healthcare company focused on the fertility market, announced today that it will effect a 1-for-8 reverse split of its issued and outstanding and authorized common stock effective as of 12:01 a.m. Eastern Time on November 28, 2025. Commencing with the opening of trading on The Nasdaq Capital Market on November 28, 2025, the Company’s common stock will trade on a post-split basis under the same tradin</description>
</item>
<item>
<title>INVO Fertility Announces Third Quarter 2025 Financial Results</title>
<link>https://6ix.com/company/invo-fertility-inc/news/invo-fertility-announces-third-quarter-133000965</link>
<guid isPermaLink="true">https://6ix.com/company/invo-fertility-inc/news/invo-fertility-announces-third-quarter-133000965</guid>
<pubDate>Mon, 17 Nov 2025 13:30:00 GMT</pubDate>
<description>SARASOTA, Fla., Nov. 17, 2025 (GLOBE NEWSWIRE) -- INVO Fertility, Inc. (Nasdaq: IVF) (“INVO Fertility” or the “Company”), a healthcare fertility company focused on the establishment, acquisition and operation of fertility clinics and related businesses and technologies, today announced third quarter 2025 financial results. Q3 2025 Financial Highlights (all metrics compared to Q3 2024 unless otherwise noted) Revenue was $1,757,094, an increase of 23% compared to $1,433,151.Consolidated clinic rev</description>
</item>
<item>
<title>INVO Fertility Partners with Heidi Health to Bring AI-Powered Tools to INVO’s Wisconsin Fertility Institute</title>
<link>https://6ix.com/company/invo-fertility-inc/news/invo-fertility-partners-heidi-health-123000974</link>
<guid isPermaLink="true">https://6ix.com/company/invo-fertility-inc/news/invo-fertility-partners-heidi-health-123000974</guid>
<pubDate>Mon, 27 Oct 2025 12:30:00 GMT</pubDate>
<description>MIDDLETON, Wis. and SARASOTA, Fla., Oct. 27, 2025 (GLOBE NEWSWIRE) -- INVO Fertility, Inc. (Nasdaq: IVF) (“INVO Fertility” or the “Company”), a healthcare fertility company focused on expanding access to advanced treatment through the establishment, acquisition and operation of fertility clinics and related businesses and technologies, today announced a strategic partnership with Heidi Health to integrate its innovative AI-powered scribe platform at INVO’s Wisconsin Fertility Institute (WFI). Bu</description>
</item>
<item>
<title>INVO Fertility to Participate in the Lytham Partners Fall 2025 Investor Conference on September 30, 2025</title>
<link>https://6ix.com/company/invo-fertility-inc/news/invo-fertility-participate-lytham-partners-213000986</link>
<guid isPermaLink="true">https://6ix.com/company/invo-fertility-inc/news/invo-fertility-participate-lytham-partners-213000986</guid>
<pubDate>Mon, 29 Sep 2025 21:30:00 GMT</pubDate>
<description>SARASOTA, Fla., Sept. 29, 2025 (GLOBE NEWSWIRE) -- INVO Fertility, Inc. (Nasdaq: IVF) (“INVO Fertility” or the “Company”), a healthcare fertility company focused on expanding access to advanced treatment through the establishment, acquisition and operation of fertility clinics and related businesses and technologies, today announced that it will participate in a webcast presentation and host one-on-one meetings with investors at the Lytham Partners Fall 2025 Investor Conference, taking place vir</description>
</item>
<item>
<title>INVO Fertility Announces Second Quarter 2025 Financial Results</title>
<link>https://6ix.com/company/invo-fertility-inc/news/invo-fertility-announces-second-quarter-213400505</link>
<guid isPermaLink="true">https://6ix.com/company/invo-fertility-inc/news/invo-fertility-announces-second-quarter-213400505</guid>
<pubDate>Thu, 14 Aug 2025 21:34:00 GMT</pubDate>
<description>SARASOTA, Fla., Aug. 14, 2025 (GLOBE NEWSWIRE) -- INVO Fertility, Inc. (Nasdaq: IVF) (“INVO Fertility” or the “Company”), a healthcare services fertility company focused on expanding access to advanced treatment through the establishment, acquisition and operation of fertility clinics and related businesses and technologies, today announced second quarter 2025 financial results. Q2 2025 Financial Highlights (all metrics compared to Q2 2024 unless otherwise noted) Revenue was $1,863,654, an incre</description>
</item>
<item>
<title>INVO Fertility Announces a 1:3 Reverse Stock Split Effective Pre-Market Opening on July 21, 2025</title>
<link>https://6ix.com/company/invo-fertility-inc/news/invo-fertility-announces-1-3-120000298</link>
<guid isPermaLink="true">https://6ix.com/company/invo-fertility-inc/news/invo-fertility-announces-1-3-120000298</guid>
<pubDate>Thu, 17 Jul 2025 12:00:00 GMT</pubDate>
<description>SARASOTA, Fla., July 17, 2025 (GLOBE NEWSWIRE) -- INVO Fertility, Inc. (“INVO”) (NASDAQ: IVF), a healthcare company focused on the fertility market, announced today that it will effect a 1-for-3 reverse split of its issued and outstanding and authorized common stock effective as of 12:01 a.m. Eastern Time on July 21, 2025. Commencing with the opening of trading on The Nasdaq Capital Market on July 21, 2025, the Company’s common stock will trade on a post-split basis under the same trading symbol</description>
</item>
<item>
<title>INVO Fertility Enhances INVOcell Technology with Expanded Awareness, Training, and Improved Pricing</title>
<link>https://6ix.com/company/invo-fertility-inc/news/invo-fertility-enhances-invocell-technology-130000599</link>
<guid isPermaLink="true">https://6ix.com/company/invo-fertility-inc/news/invo-fertility-enhances-invocell-technology-130000599</guid>
<pubDate>Wed, 09 Jul 2025 13:00:00 GMT</pubDate>
<description>SARASOTA, Fla., July 09, 2025 (GLOBE NEWSWIRE) -- INVO Fertility, Inc. (Nasdaq: IVF) (“INVO Fertility” or the “Company”), a healthcare company focused on the fertility market, today announced further efforts to drive its comprehensive strategy to enhance fertility services through expanded clinical and embryology training support and improved pricing for its innovative INVOcell® technology. This underscores the Company’s dual mission as an innovator of cutting-edge fertility solutions and a prov</description>
</item>
</channel>
</rss>